Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHB Wealth Management, LLC
Latest Disclosed Ownership56,970 shares
Latest Disclosed Value $ 7,940,039
HB Wealth Management, LLC reports 10.72% increase in ownership of GILD / Gilead Sciences, Inc.

On April 27, 2026 - HB Wealth Management, LLC filed a 13F-HR form disclosing ownership of 56,970 shares of Gilead Sciences, Inc. (CH:GILD) valued at $7,940,039 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 51,454 shares of Gilead Sciences, Inc.. This represents a change in shares of 10.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F GILEAD SCIENCES COM 375558103 56,970 5,516 10.72 7,940 25.73 0.0514
2026-01-28 2025-12-31 13F GILEAD SCIENCES COM 375558103 51,454 4,266 9.04 6,315 20.58 0.0408
2025-10-23 2025-09-30 13F GILEAD SCIENCES COM 375558103 47,188 13,249 39.04 5,238 39.21 0.0355
2025-07-17 2025-06-30 13F GILEAD SCIENCES COM 375558103 33,939 -19 -0.06 3,763 -1.13 0.0299
2025-05-07 2025-03-31 13F GILEAD SCIENCES COM 375558103 33,958 7,547 28.58 3,805 56.01 0.0319
2025-01-15 2024-12-31 13F GILEAD SCIENCES COM 375558103 26,411 8,406 46.69 2,440 61.63 0.0249
2024-10-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 18,005 -380 -2.07 1,510 19.67 0.0162
2024-07-26 2024-06-30 13F GILEAD SCIENCES COM 375558103 18,385 2,135 13.14 1,261 5.97 0.0147
2024-04-30 2024-03-31 13F GILEAD SCIENCES COM 375558103 16,250 -2,333 -12.55 1,190 -20.93 0.0150
2024-01-16 2023-12-31 13F GILEAD SCIENCES COM 375558103 18,583 2,689 16.92 1,505 26.36 0.0216
2023-10-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 15,894 4,222 36.17 1,191 32.48 0.0192
2023-07-13 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,672 93 0.80 900 -6.35 0.0144
2023-04-13 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,579 572 5.20 961 1.69 0.0167
2023-01-20 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,007 2,129 23.98 945 72.26 0.0172
2022-10-19 2022-09-30 13F GILEAD SCIENCES COM 375558103 8,878 1,666 23.10 548 22.87 0.0117
2022-07-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 7,212 27 0.38 446 4.45 0.0091
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 7,185 3,316 85.71 427 51.96 0.0079
2022-02-15 2021-12-31 13F GILEAD SCIENCES COM 375558103 3,869 3,869 281 0.0057
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.